Tag: Zynerba Pharmaceuticals


Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) Gains the Following Presentation of a Poster On Zygel in DEE Treatment

Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) gained after presenting a poster at the 2021 SLEEP 35th Annual Meeting of the Associated Sleep Societies.  Zynerba presents a poster in ZYN002. The poster was titled, “Impact of ZYN002 Cannabidiol Transdermal Gel on Sleep in Children and Adolescents with Developmental and Epileptic Encephalopathies and […]